AlphaMadera

YDES YD Bio Limited Ordinary Shares

$4.77

Stable Earnings Power 40%

P/Adj-EPS × Normalized Multiple

Strong · Conviction

Overvalued

Trading 655.9% above fair value

You pay $4.77

Bear $0.54

Fair $0.63

Bull $0.72

Bear $0.54 -88.7% $0.03 × 18x P/E

Fair $0.63 -86.8% $0.03 × 21x P/E

Bull $0.72 -84.9% $0.03 × 24x P/E

Adjust Assumptions

P/E Multiple

21.0x

Adjusted EPS

0.03$

Key Value Driver

Normalized P/E multiple (21x base case)

Terminal Value % of EV

Implied Market Multiple 158.7x

Market is pricing in (growth)

Summary

Applying a 21x P/E to adjusted EPS of $0.03, the base-case value is $0.63 per share.

Warnings

⚠ This stock is 78% below its 52-week high, with weak or declining earnings. That combination often signals real trouble, even though the valuation below is based on other fundamentals.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples